2025Bmc Infectious Diseases : 10.1186/s12879-025-12211-8
Guidelines on reporting and assessing dynamic mathematical models of infectious diseases: a scoping review
Chaturvedi M, Bartz A, Denkinger C, Klett-Tammen C, Kretzschmar M, Kuhlmann A, Lange B, Marx F, Mikolajczyk R, Monsef I, Nguyen H, Suer J, Skoetz N, Jaeger V, Karch A
2025The Journal of Infectious Diseases : jiaf654
Transient interferon-driven NK cell activation in acute hepatitis C
Strunz B, Zhan Q, Khera T, Hengst J, Jankovic M, Deterding K, Niehrs A, Cornberg M, Xu C, Wedemeyer H, Björkström N
2025Plos One20 (12) : e0337890
Dynamic growth risk of incidentally detected gallbladder polyps-A retrospective, single-center analysis
Heinrich S, Ten Thoren P, Behrendt P, Hagenah J, Wedemeyer H, Potthoff A, Maasoumy B
2025Journal of Autoimmunity158 : 103517
Humoral correlates of clinical response to thymectomy in myasthenia gravis
Sousa C, Terroba-Navajas P, Tzartos J, Orešković I, Pučić-Baković M, Lauc G, Bartsch Y, Kaminski H, Lünemann J
2025Blood Advances9 (23) : 6076-6089
Identification of 4 autophagy-related genetic variants as risk factors for chronic lymphocytic leukemia
Cabrera-Serrano A, Sánchez-Maldonado J, Rodríguez-Sevilla J, Reyes-Zurita F, Collado R, Puiggros A, Cornejo-Calvo E, García-Martín P, Ter Horst R, Benavente Y, Jerez A, Landi S, Espinet B, Maffei R, López-Nevot M, Ramos-Campoy S, González-Olmedo C, Chen-Liang T, Moreno V, Jannus F, Marcos-Gragera R, Carretero-Fernández M, Sampaio-Marques B, Gámez I, García-Álvarez M, Camp N, Dierssen-Sotos T, Kamaso J, Pérez E, Norman A, Luppi M, Li Y, Alcoceba M, Campa D, de San José S, Marasca R, Ludovico P, Clay-Gilmour A, Canzian F, Ibañez M, Netea M, McKay J, Casabonne D, Berndt S, Slager S, Sainz J
2025Mabs17 (1) : 2465391
Combinatorial Fc modifications for complementary antibody functionality
Bartsch Y, Webb N, Burgess E, Kang J, Lauffenburger D, Julg B
2025Oncoimmunology14 (1) : 2547271
Low triglyceride levels are associated with increased risk of immune-related adverse events in patients receiving immune checkpoint inhibitors
Möhn N, Narten E, Duzzi L, Thomas J, Grote-Levi L, Beutel G, Fröhlich T, Bollmann B, Wirth T, von Wasielewski I, Gutzmer R, Heidel F, Pessler F, Zobl W, Schuchardt S, Ivanyi P, Nay S, Skripuletz T
2025Gut Microbes17 (1) : 2487209
Distinct clusters of bacterial and fungal microbiota in end-stage liver cirrhosis correlate with antibiotic treatment, intestinal barrier impairment, and systemic inflammation
Buttler L, Velázquez-Ramírez D, Tiede A, Conradi A, Woltemate S, Geffers R, Bremer B, Spielmann V, Kahlhöfer J, Kraft A, Schlüter D, Wedemeyer H, Cornberg M, Falk C, Vital M, Maasoumy B
2025Nature Communications16 (1) : 10219
Directed evolution of phages in biofilms enhances Pseudomonas aeruginosa control through improved lipopolysaccharide recognition
Meneses L, Valentová L, Santos S, Erdmann J, Crabbé A, Plevka P, Häussler S, Pires D, Coenye T, Azeredo J
2025Gastroenterology : S0016-5085(25)06045-7
High Prevalence and Local Dissemination of Daptomycin-Resistance Mutations for Enterococcus faecium in Cirrhotic Patients
Deng Z, Safaei N, Schütte S, Ohlendorf V, Maasoumy B, Mchardy A